Conduction System Pacing Shows Promise for Heart Failure Patients with Right Bundle Branch Block

Is CSP the Next Leap in Heart Failure Therapy?

Conduction system pacing (CSP) significantly improves cardiac function in heart failure patients with right bundle branch block, according to a new observational study. Researchers demonstrated that CSP using either His bundle pacing or left bundle branch area pacing produced substantial improvements in left ventricular function, myocardial work efficiency, and clinical outcomes in a patient population that traditionally responds poorly to conventional cardiac resynchronization therapy.

The single-center study conducted between January 2021 and January 2024 enrolled 20 consecutive patients with heart failure with reduced ejection fraction (HFrEF) and right bundle branch block (RBBB), successfully implementing CSP in 16 patients. Researchers observed a significant reduction in QRS duration (25 ± 20 ms, p < 0.001) and improvements in left ventricular ejection fraction from 27 ± 7% to 33 ± 9% after six months. The study utilized advanced echocardiographic techniques including speckle tracking and myocardial work assessments to evaluate the mechanisms behind these improvements. Most notably, CSP decreased the extent of left ventricular mechanical dyssynchrony measured by peak strain dispersion, which fell from 126 ± 28 ms to 96 ± 23 ms. This was accompanied by significant improvements in global myocardial work index (from 582 ± 277 mmHg% to 840 ± 306 mmHg%) and global work efficiency (from 71 ± 7% to 77 ± 8%).

The findings address a significant clinical challenge in cardiac resynchronization therapy (CRT). While conventional biventricular pacing has become a standard approach for heart failure patients with left bundle branch block, its effectiveness in patients with RBBB has been limited. "CSP with either His bundle pacing or left bundle branch area pacing decreased LV mechanical dyssynchrony, which might lead to improved myocardial work and efficiency," the researchers noted in their conclusions. This suggests that CSP could offer a more physiological approach to cardiac resynchronization in this challenging patient population. The improvement in electrical synchronization translated to meaningful clinical benefits, with NT-proBNP levels decreasing significantly and 13 of 16 patients showing improvement of at least one NYHA functional class.

What Makes the Procedure Stand Out Clinically?

The study compared two CSP approaches – His bundle pacing (HBP) and left bundle branch area pacing (LBBAP). While both techniques showed promise, LBBAP demonstrated more favorable procedural metrics including lower pacing thresholds. HBP was associated with voltage-dependent attenuation of the RBBB pattern, particularly with non-selective His bundle capture, suggesting a mechanism related to modification of the conduction block. LBBAP achieved QRS reduction in 60% of patients, though two patients with left anterior hemiblock experienced QRS prolongation, highlighting the importance of patient selection. The researchers employed anodal capture from the ring electrode with bipolar stimulation in 30% of LBBAP cases to achieve further QRS reduction, a technique that has been reported in up to 48% of patients in larger collaborative studies.

The study findings align with emerging evidence that CSP may provide superior resynchronization compared to conventional biventricular pacing in selected patients. The International LBBAP Collaborative Study previously demonstrated that reduction in paced QRS duration compared to baseline was the only independent predictor of echocardiographic response after LBBAP in RBBB patients. The current study extends these findings by demonstrating improvements in myocardial work parameters, which have been correlated with long-term prognosis in various cardiac conditions. The researchers hypothesized that improved mechanical synchrony achieved through CSP might be the link between electrical resynchronization and better clinical outcomes.

How Do Study Limitations Shape Future Research?

Despite these promising results, the authors acknowledge significant limitations. As a single-center observational study with a small sample size, it lacks statistical power for robust subgroup analyses comparing HBP with LBBAP. The absence of a control group receiving either optimal medical therapy alone or conventional biventricular pacing makes it difficult to establish definitive causality. "These data should be viewed as hypothesis-generating until being validated by a randomized trial including an adequate number of patients," the researchers cautioned. Additionally, the study relied on intermediate endpoints such as changes in LVEF and functional status rather than hard clinical outcomes like mortality.

The findings nevertheless point to a potential paradigm shift in cardiac resynchronization strategies for heart failure patients with RBBB. As device manufacturers continue to refine leads and delivery systems for CSP, the technique may gain broader adoption, particularly in patients who have been challenging to treat with conventional approaches. The integration of advanced imaging techniques to assess mechanical synchrony and myocardial work could further help optimize patient selection and therapy delivery, potentially improving outcomes in this difficult-to-treat population.

Can Industry Trends Accelerate CSP Adoption?

Industry Context: This study represents a significant development in the cardiac rhythm management sector, where manufacturers have been increasingly focused on physiological pacing approaches. As CSP techniques mature and demonstrate clinical benefits in specific patient populations, companies like Medtronic, Abbott, and Boston Scientific may accelerate development of specialized leads and delivery systems. The findings also highlight the growing importance of integrating advanced imaging with electrophysiological interventions to optimize therapy delivery and patient selection, potentially creating new opportunities for cross-sector collaboration between device manufacturers and imaging technology providers.

Summary

A recent observational study demonstrates that conduction system pacing (CSP) significantly improves cardiac function in heart failure patients with right bundle branch block, a population that traditionally responds poorly to conventional cardiac resynchronization therapy. The single-center study, conducted between January 2021 and January 2024, successfully implemented CSP in 16 of 20 enrolled patients with heart failure with reduced ejection fraction and right bundle branch block. Researchers observed substantial improvements in left ventricular ejection fraction, which increased from 27% to 33% after six months, along with significant reductions in QRS duration and left ventricular mechanical dyssynchrony. The study utilized advanced echocardiographic techniques including speckle tracking and myocardial work assessments to evaluate treatment mechanisms. Both His bundle pacing and left bundle branch area pacing approaches showed promise, with left bundle branch area pacing demonstrating more favorable procedural metrics including lower pacing thresholds. The improvement in electrical synchronization translated to meaningful clinical benefits, with 13 of 16 patients showing improvement of at least one New York Heart Association functional class. Despite these encouraging results, the authors acknowledge significant limitations including the small sample size, absence of a control group, and reliance on intermediate endpoints rather than hard clinical outcomes. The findings suggest that CSP could offer a more physiological approach to cardiac resynchronization in this challenging patient population and may represent a potential paradigm shift in treatment strategies, though validation through larger randomized trials is needed before definitive conclusions can be drawn about its superiority over conventional approaches.